Blog
05-11-2023Cross-posted from FDA News Release Today, the U.S. Food and Drug Administration finalized recommendations for assessing blood dono...
FDA
FDA Finalizes Move to Recommend Individual Risk Assessment to Determine Eligibility for Blood Donations - Blog
FDA Proposes Individual Risk Assessment for Blood Donations, While Continuing to Safeguard U.S. Blood Supply 01-27-2023Cross-posted from FDA News Release The U.S. Food and Drug Administration today announced it is proposing a change from time-based... - Blog
FDA Approves New HIV Drug for Adults with Limited Treatment Options 01-04-2023Cross-posted from FDA News Release [On December 22, 2022], the U.S. Food and Drug Administration approved Sunlenca (lenacapavir),... - Blog
Biden-Harris Administration Bolsters Monkeypox Response; HHS Secretary Becerra Declares Public Health Emergency 08-05-2022Cross-posted from HHS Press Office U.S. Department of Health and Human Services Secretary Xavier Becerra announced today that he w... - Blog
FDA Permits Marketing of First Condom Specifically Indicated for Anal Intercourse 03-10-2022Cross-posted from FDA Newsroom Other FDA-Cleared Condoms Can Continue to Be Used for Contraception and to Prevent STIs[On February... - Blog
Participants Needed in Blood Donor Study: Could Lead to Eligibility Changes for Men Who Have Sex with Men 01-26-2022A pilot study funded by the U.S. Food and Drug Administration (FDA) that could potentially lead to changes to blood donor eligibi... - Blog
FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention 12-21-2021Cross-posted from FDA Press room Drug Given Every Two Months Rather Than Daily Pill is Important Tool in Effort to End the HIV Epi... - Blog
FDA Approves First Extended-Release, Injectable Drug Regimen for Adults Living with HIV 01-22-2021@US_FDA has approved Cabenuva (cabotegravir and rilpivirine), the first injectable, complete treatment regimen for people with #HIV that is administered once a.… - Blog
Federal Agencies Highlight Ongoing Efforts to End HIV for World AIDS Day 12-07-2020As we look back on World AIDS Day 2020, our colleagues across the federal government spoke out about progress to date in our collective response to HIV and reco… - Blog
FDA Approves New HIV Treatment for Patients With Limited Treatment Options 07-14-2020Cross-posted from U.S. Food and Drug Administration[On July 2, 2020], the U.S. Food and Drug Administration approved Rukobia (fos... - Blog
FDA Approves Drug to Treat Infants and Children with HIV 06-16-2020On June 12, 2020, the U.S. Food and Drug Administration (FDA) approved Tivicay (dolutegravir) tablets and Tivicay PD (dolutegravi... - Blog
New FDA Information on OraQuick In-Home HIV Test 06-11-2020The U.S. Food and Drug Administration (FDA) has published new information on the OraQuick In-Home HIV Test. This is the only FDA-... - Blog
President Trump Announces Remdesivir Authorized for Emergency COVID-19 Treatment, Discusses Ending HIV and Hepatitis C 05-05-2020On May 1, 2020, the President announced that the investigational antiviral drug remdesivir has been authorized by the U.S. Food and Drug Administration for emer… - Blog
Coronavirus (COVID-19) Update: FDA Provides Updated Guidance to Address the Urgent Need for Blood During the Pandemic 04-02-2020Cross-posted from U.S. Food and Drug AdministrationStatement from: Director - Center for Biologics Evaluation and Research (CBER... - Blog
FDA Launches Mobile-Friendly Database with Information on Life-Saving HIV Drugs 02-06-2020Interactive tool offers information on ARVs eligible for purchase under the President’s Emergency Plan for AIDS Relief program - Blog
FDA Approves Second Drug to Prevent HIV Infection as Part of Ongoing Efforts to End the HIV Epidemic 10-03-2019The FDA today approved Descovyin at-risk adults and adolescents weighing at least 35kg for HIV-1 pre-exposure prophylaxis (PrEP) to reduce the risk of HIV... - Blog
FDA’s Response to HIV: A Perspective from the Commissioner 10-03-2019FDA’s Acting Commissioner discusses the agency’s roles spanning the entire spectrum of HIV research and product development. - Blog
FDA Approves First Two-drug Complete Regimen for HIV-infected Patients Who Have Never Received Antiretroviral Treatment 04-09-2019The FDA approved Dovato, the first FDA-approved two-drug, fixed-dose, complete regimen for HIV-infected adults who have never received treatment for HIV. - Blog
Secretary Azar Addresses CDC’s National HIV Prevention Conference 03-20-2019The second plenary session at the CDC’s 2019 National HIV Prevention Conference featured remarks by HHS Secretary Alex Azar. - Blog
While You Were Busy: U.S. Agency Posts Commemorating WAD 12-03-2018World AIDS Day is always a busy time for the HIV community. For your convenience, we have recapped some of our 2018 World AIDS Day blog posts.